The performance of marginal structural models for estimating risk differences and relative risks using weighted univariate generalized linear models
Austin PC. Stat Methods Med Res. 2024; Apr 24 [Epub ahead of print].
Introduction — Direct-acting antivirals (DAAs) are curative treatments for hepatitis C. However, initiation of these treatments requires adequate healthcare access. Coronavirus 2019 (COVID-19) resulted in restrictions to healthcare services in March 2020. We examined the impact of COVID-19 on the number of individuals dispensed DAAs.
Methods — This is a cross-sectional study examining the number of individuals dispensed DAAs in Ontario, Canada, from 2018 to 2020. Time-series models determined the impact of healthcare restrictions on DAA dispensations.
Results — Healthcare restrictions resulted in a 49.3% decrease in DAA dispensations (P = 0.026).
Discussion — COVID-19-related healthcare restrictions significantly affected access to DAAs. Studies exploring the long-term effects on reduced treatment are needed.
Konstantelos N, Shakeri A, McCormack D, Feld JJ, Gomes T, Tadrous M. Am J Gastroenterol. 2021; 116(8):1738-40. Epub 2021 Apr 28.
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.